A detailed history of Tyche Wealth Partners LLC transactions in Novartis Ag stock. As of the latest transaction made, Tyche Wealth Partners LLC holds 2,247 shares of NVS stock, worth $235,642. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,247
Previous 2,244 0.13%
Holding current value
$235,642
Previous $239 Million 8.18%
% of portfolio
0.06%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$106.13 - $120.89 $318 - $362
3 Added 0.13%
2,247 $258 Million
Q2 2024

Jul 18, 2024

BUY
$92.57 - $107.37 $647 - $751
7 Added 0.31%
2,244 $239 Million
Q1 2024

Apr 23, 2024

BUY
$95.27 - $108.47 $9,527 - $10,847
100 Added 4.68%
2,237 $216 Million
Q4 2023

Jan 30, 2024

BUY
$92.27 - $101.54 $197,180 - $216,990
2,137 New
2,137 $216 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $226B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Tyche Wealth Partners LLC Portfolio

Follow Tyche Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tyche Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tyche Wealth Partners LLC with notifications on news.